Canopy Biosciences

Canopy Biosciences is a biotechnology company that provides products and services for gene editing and personalized medicine. The gene editing technology, called TUNR, targets translational elongation by inserting polyA tracks into targeted coding regions of the genome. This modification then reduces the level of mRNA transcribed from the gene, thereby suppressing protein expression. Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services by licensing key technologies in the fields of genetic engineering and personalized medicine. Canopy was founded in 2016 and has offices and laboratories in St. Louis, MO.